Microorganism |
MIC50 (μg/ml) |
MIC90 (μg/ml) |
Range (μg/ml) |
Antimicrobial  |
Reference |
Streptococci (Viridans group + erythromycin-susceptible) |
- |
1 |
? - ? |
Linezolid (PNU-100766, U-100766, Zyvox)  |
1112 |
Streptococci (Viridans group + erythromycin-susceptible) |
- |
1 |
? - ? |
Vancomycin (Vancocyn, Lyphocin)  |
1112 |
Streptococci (Viridans group + penicillin-intermediate) |
≤0.01 |
≤0.01 |
≤0.01 - 0.25 |
Oritavancin (LY333328)  |
4 |
Streptococci (Viridans group + penicillin-intermediate) |
0.03 |
0.25 |
≤0.01 - 0.5 |
Teicoplanin (Targocid)  |
43 |
Streptococci (Viridans group + penicillin-intermediate) |
>0.06 |
>8 |
? - ? |
Clindamycin (Cleocin)  |
39 |
Streptococci (Viridans group + penicillin-intermediate) |
0.12 |
0.25 |
? - ? |
Tigecycline (GAR-936, Tigacyl)  |
39 |
Streptococci (Viridans group + penicillin-intermediate) |
0.25 |
1 |
≤0.06 - 4 |
Cefotaxime (Cephotaxime, Claforan)  |
43 |
Streptococci (Viridans group + penicillin-intermediate) |
0.3 |
0.5 |
0.12 - 0.5 |
Vancomycin (Vancocyn, Lyphocin)  |
43 |
Streptococci (Viridans group + penicillin-intermediate) |
0.5 |
1 |
0.5 - 2 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin)  |
43 |
Streptococci (Viridans group + penicillin-intermediate) |
0.5 |
1 |
? - ? |
Quinupristin/Dalfopristin (Synercid)  |
39 |
Streptococci (Viridans group + penicillin-intermediate) |
0.5 |
1 |
? - ? |
Vancomycin (Vancocyn, Lyphocin)  |
39 |
Streptococci (Viridans group + penicillin-intermediate) |
0.5 |
2 |
? - ? |
Ceftriaxone (Rocephin)  |
39 |
Streptococci (Viridans group + penicillin-intermediate) |
>1 |
>4 |
? - ? |
Levofloxacin (Levaquin, Quixin)  |
39 |
Streptococci (Viridans group + penicillin-intermediate) |
>1 |
>8 |
? - ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin)  |
39 |
Streptococci (Viridans group + penicillin-intermediate) |
≤2 |
≤2 |
? - ? |
Amoxicillin-clavulanate  |
39 |
Streptococci (Viridans group + penicillin-intermediate) |
>2 |
>4 |
≤0.25 - >4 |
Erythromycin (E-mycin, Ery-tab, Benzamycin)  |
43 |
Streptococci (Viridans group + penicillin-intermediate) |
>8 |
>8 |
? - ? |
Tetracycline (Sumycin, Achromycin V, Steclin)  |
39 |
Streptococci (Viridans group + penicillin-resistant) |
0.01 |
0.06 |
0.01 - 0.06 |
Oritavancin (LY333328)  |
4 |
Streptococci (Viridans group + penicillin-resistant) |
0.01 |
0.5 |
≤0.01 - 0.5 |
Teicoplanin (Targocid)  |
43 |
Streptococci (Viridans group + penicillin-resistant) |
0.03 |
0.06 |
0.02 - 0.12 |
Tigecycline (GAR-936, Tigacyl)  |
476 |
Streptococci (Viridans group + penicillin-resistant) |
0.12 |
16 |
0.06 - 32 |
Minocycline (Minocycline hydrochloride, Minocin)  |
476 |
Streptococci (Viridans group + penicillin-resistant) |
0.25 |
0.25 |
0.06 - 0.25 |
Sparfloxacin (AT-4140, Zagam)  |
117 |
Streptococci (Viridans group + penicillin-resistant) |
0.25 |
0.25 |
0.125 - 4 |
Moxifloxacin (BAY 12-8039, Avelox)  |
19 |
Streptococci (Viridans group + penicillin-resistant) |
0.25 |
0.5 |
0.25 - 0.5 |
Sparfloxacin (AT-4140, Zagam)  |
374 |
Streptococci (Viridans group + penicillin-resistant) |
0.25 |
16 |
0.02 - 32 |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin)  |
476 |
Streptococci (Viridans group + penicillin-resistant) |
0.25 |
64 |
0.02 - 64 |
Tetracycline (Sumycin, Achromycin V, Steclin)  |
476 |
Streptococci (Viridans group + penicillin-resistant) |
0.3 |
0.5 |
0.25 - 1 |
Vancomycin (Vancocyn, Lyphocin)  |
43 |
Streptococci (Viridans group + penicillin-resistant) |
0.5 |
0.5 |
0.5 - 8 |
Clindamycin (Cleocin)  |
1396 |